ABBOTT TESTPACK RSV 2027-16

MAUDE Adverse Event Report

MAUDE data represents reports of adverse events involving medical devices. This maude entry was filed from a 05 report with the FDA on 1997-03-25 for ABBOTT TESTPACK RSV 2027-16 manufactured by Abbott Laboratories.

Event Text Entries

[7771159] Investigation results: no customer return received. File material performed appropriately meeting all performance criteria. Known negative samples yielded negative results. Negatives were clear, clean, and easy to interpret. Known positives were picked up at appropriate levels with bar intensities acceptable. In response to the customer stating that a faintly positive result is interpreted by the majority of techs as negative, any color on the vertical bar is a positive result. Since the customer did not return the kit, patient sample, or a sample of their transport media for evaluation, further analysis cannot be performed. The complaint was not confirmed. Evaluation complete-final report.
Patient Sequence No: 1, Text Type: N, H10


[15483743] The account stated they obtained discrepant results when using the rsv kit. The account stated that when a rapid assay is run, the negative assays are sent to a reference lab for fa. The method of fa is unkown. The account stated they had a incident which gave a negative result on the kit and positive on fa, but when the sample was repeated in the lab it was positive. The reporter attributed this to opertor error as the kit was allowed to sit out at room temperature for 5-10 minutes before use. Label states kit reagents and reaction discs must be at room temperature prior to use (minimum 30 minutes). Additional info indicates they had another sample which was negative on the kit and positive with fa. One pt was a baby admitted with upper respiratory problems. The negative result from rsv kit impacted pt since treatment was delayed for about 24 hours until fa result received and pt was not treated or isolated. No additional info on pts available due to confidentiality issues.
Patient Sequence No: 1, Text Type: D, B5


MAUDE Entry Details

Report Number1451914-1997-00018
MDR Report Key81016
Report Source05
Date Received1997-03-25
Date of Report1997-03-25
Date of Event1997-01-20
Date Mfgr Received1997-02-24
Device Manufacturer Date1996-12-01
Date Added to Maude1997-04-04
Event Key0
Report Source CodeManufacturer report
Manufacturer LinkY
Number of Patients in Event0
Adverse Event Flag3
Product Problem Flag3
Reprocessed and Reused Flag0
Health Professional3
Initial Report to FDA3
Report to FDA3
Event Location3
Single Use3
Previous Use Code3
Event Type3
Type of Report3

Device Details

Brand NameABBOTT TESTPACK RSV
Generic NameEIA FOR THE RAPID DETECTION OF RSV
Product CodeGQG
Date Received1997-03-25
Model NumberNA
Catalog Number2027-16
Lot Number24251M100
ID NumberNA
Device Expiration Date1997-10-09
OperatorHEALTH PROFESSIONAL
Device AvailabilityN
Device Age*
Device Eval'ed by MfgrY
Implant FlagN
Date Removed*
Device Sequence No1
Device Event Key80461
ManufacturerABBOTT LABORATORIES
Manufacturer AddressINTERSECTION U.S. 41 & 22ND ST NORTH CHICAGO IL 60064 US
Baseline Brand NameTESTPACK RSV
Baseline Generic NameEIA FOR THE RAPID DETECTION OF RSV
Baseline Model NoNA
Baseline Catalog No2027-16
Baseline IDNA
Baseline Device FamilyTESTPACK RSV
Baseline Shelf Life ContainedY
Baseline Shelf Life [Months]10
Baseline PMA FlagN
Baseline 510K PMNY
Premarket NotificationK874127
Baseline PreamendmentN
Baseline TransitionalN
510k ExemptN


Patients

Patient NumberTreatmentOutcomeDate
101. Other 1997-03-25

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.